# US 2023/0272397 A1 · Methods for improving the health of porcine species by targeted inactivation of cd163

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0272397 A1
- Document ID: US20230272397A1
- Status: Published application
- Kind: A1
- Application number: 18/192,492
- Filed: 2023-03-29
- Published: 2023-08-31
- Earliest claimed: 2020-05-05
- Assignees: Genus, Inc.
- Applicants: Genus PLC
- Inventors: Andrew Mark Cigan; Jonathan Edward Lightner; Matthew Scott Culbertson; William Thomas Christianson; Benjamin Beaton; Brian Burger; Dylan Barnes; Matthew Campbell
- Web page: https://patentgrep.com/patent/US20230272397A1

## CPC

- A01K 67/0276: Knock-out vertebrates
- C12N 15/113: Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)}
- A01K 67/0275: Genetically modified vertebrates, e.g. transgenic
- C07K 14/70596: {Molecules with a "CD"-designation not provided for elsewhere}
- C12N 9/226: {Class 2 CAS enzyme complex, e.g. single CAS protein}
- C12N 15/8778: {Swine embryos}
- C12N 15/90: Stable introduction of foreign DNA into chromosome
- C12Q 1/6876: Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- A01K 2217/052: inducing gain of function
- A01K 2217/075: inducing loss of function, i.e. knock out
- A01K 2227/108: Swine
- A01K 2267/02: Animal zootechnically ameliorated
- C12N 2310/20: involving clustered regularly interspaced short palindromic repeats [CRISPR]
- C12N 2320/34: Allele or polymorphism specific uses
- C12Q 2600/124: Animal traits, i.e. production traits, including athletic performance or the like
- A01K: ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The present disclosure relates methods and compositions useful for prevention of porcine reproductive and respiratory syndrome virus (PRRSv) in animals, including animals of the species Sus scrofa. The present teachings relate to swine wherein at least one allele of a CD163 gene has been inactivated, and to specific methods and nucleic acid sequences used in gene editing to inactivate the CD163 gene. Swine wherein both alleles of the CD163 gene are inactivated are resistant to porcine reproductive and respiratory syndrome virus (PRRSv). Elite lines comprising homozygous CD163 edited genes retain their superior properties

## Claims

### Claim 1

A pig whose genome comprises a CD163 gene comprising a nucleic acid sequence of SEQ ID NO: 453, wherein the CD163 gene expresses a modified CD163 protein that exhibits reduced uptake of porcine reproductive and respiratory syndrome virus (PRRSV) relative to a wild-type CD163 protein.

### Claim 2 (depends on 1)

A cell isolated from the pig of claim 1.

### Claim 3 (depends on 1)

An isolated cell line obtained from the pig of claim 1.

### Claim 4 (depends on 1)

An isolated fibroblast cell line obtained from the pig of claim 1.

### Claim 5 (depends on 1)

The pig of claim 1, wherein the CD163 gene is heterozygous for the nucleic acid sequence of SEQ ID NO: 453.

### Claim 6 (depends on 5)

A cell isolated from the pig of claim 5.

### Claim 7 (depends on 5)

An isolated cell line obtained from the pig of claim 5.

### Claim 8 (depends on 5)

An isolated fibroblast cell line obtained from the pig of claim 5.

### Claim 9 (depends on 1)

The pig of claim 1, wherein the CD163 gene is homozygous for the nucleic acid sequence of SEQ ID NO: 453.

### Claim 10 (depends on 9)

A cell isolated from the pig of claim 9.

### Claim 11 (depends on 9)

An isolated cell line obtained from the pig of claim 9.

### Claim 12 (depends on 9)

An isolated fibroblast cell line obtained from the pig of claim 9.

### Claim 13

A method of producing one or more pigs whose genome comprises a CD163 gene comprising a nucleic acid sequence of SEQ ID NO: 453, wherein the CD163 gene expresses a CD163 protein that exhibits reduced uptake of porcine reproductive and respiratory syndrome virus (PRRSV) relative to a wild-type CD163 protein, the method comprising:
a) introducing:
i) a Cas9 protein or a nucleic acid sequence encoding a Cas9 protein;
ii) a guide RNA (gRNA) comprising the nucleic acid sequence of SEQ ID NO: 249; and
iii) a gRNA comprising the nucleic acid sequence of SEQ ID NO: 256 into an isolated pig cell;
b) producing a pig from the isolated pig cell.

### Claim 14 (depends on 13)

The method of claim 13, wherein the isolated pig cell is a fertilized oocyte and further wherein the producing comprises implanting the fertilized oocyte into a surrogate mother.

### Claim 15 (depends on 13)

The method of claim 13, further comprising breeding the pig to a wild-type pig to create a plurality of first-generation progeny.

### Claim 16 (depends on 15)

The method of claim 15, further comprising breeding the plurality of first-generation progeny to produce a plurality of second-generation progeny.

### Claim 17 (depends on 13)

The method of claim 13, wherein individuals from the plurality of second-generation progeny are homozygous for the nucleic acid sequence of SEQ ID NO: 453.

### Claim 18 (depends on 13)

The method of claim 13, wherein the isolated pig cell is a fibroblast cell.

### Claim 19 (depends on 13)

A pig produced by the method of claim 13.

### Claim 20 (depends on 13)

The method of claim 13, wherein the producing comprises nuclear transfer of the isolated pig cell or a cell derived therefrom to produce a pig embryo.

### Claim 21 (depends on 20)

The method of claim 20, further comprising implanting the pig embryo obtained from the nuclear transfer into a surrogate mother.

### Claim 22 (depends on 13)

The method of claim 13, wherein the isolated pig cell is a pig embryo or zygote.

### Claim 23 (depends on 22)

The method of claim 22, further comprising implanting the pig embryo or zygote into a surrogate mother.
